Edition:
United Kingdom

Guerbet SA (GRBT.PA)

GRBT.PA on Paris Stock Exchange

57.20EUR
10:02am BST
Change (% chg)

€0.20 (+0.35%)
Prev Close
€57.00
Open
€57.90
Day's High
€58.10
Day's Low
€57.20
Volume
663
Avg. Vol
5,477
52-wk High
€87.65
52-wk Low
€50.00

Chart for

About

Guerbet SA is a France-based pharmaceutical group specialized in the manufacture and marketing of medical imaging contrast agents destined for diagnostic purposes. It produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents... (more)

Overall

Beta: 0.53
Market Cap(Mil.): €1,061.47
Shares Outstanding(Mil.): 12.50
Dividend: 0.85
Yield (%): 1.00

Financials

  GRBT.PA Industry Sector
P/E (TTM): 37.00 30.93 32.76
EPS (TTM): 2.29 -- --
ROI: 4.32 15.07 14.61
ROE: 9.69 16.59 16.33

BRIEF-Guerbet Announces Acquisition Of A New Microsphere Technology

* GUERBET ANNOUNCES THE ACQUISITION OF A NEW MICROSPHERE TECHNOLOGY TO STRENGTHEN ITS INTERVENTIONAL IMAGING RANGE

26 Apr 2018

BRIEF-Guerbet Expects 2018 Revenue In-Line With 2017

* FOR 2018, EXPECTS REVENUE IN-LINE WITH 2017 AT CONSTANT EXCHANGE RATES

18 Apr 2018

BRIEF-Guerbet Q1 Revenue Stable At 196.5 Million Euros

* Q1 REVENUE EUR 196.5 MILLION VERSUS EUR 197.3 MILLION YEAR AGO

18 Apr 2018

BRIEF-Guerbet Partners With Lausanne’S CHUV And CET To Launch Clinical Study

* PARTNERS WITH LAUSANNE’S CHUV AND CET TO LAUNCH A CLINICAL STUDY

13 Apr 2018

BRIEF-Guerbet FY EBITDA Increased By 22.4 Percent To 130 Million Euros

* FY NET INCOME EUR 46.2 MILLION VERSUS EUR 28.9 MILLION YEAR AGO

27 Mar 2018

Earnings vs. Estimates